Latest filing published 15 Sept 2021 for DiaMedica Therapeutics Inc., €48k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Harry W. Alcorn Jr.: trading record in brief
Harry W. Alcorn Jr. is a declared insider of DiaMedica Therapeutics Inc. (senior executive), with filings sourced from SEC (Form 4). Between 11 December 2018 and 15 September 2021, the trades on record add up to 8 filings.
On the market, this insider has only ever bought: 7 purchases, €124k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2021: 4 purchases and no sales on the market.
A typical purchase (the median) is worth €3,522. On 6 out of 7 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 15 September 2021 came the latest disclosure, an open-market purchase for €48k in DiaMedica Therapeutics Inc. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Harry W. Alcorn Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 shares@ US$3.797347.9% of flowVoting Common Shares, no par value per shareSEC:0001235802-21-000119:0Canonical exit: 14 Dec 2021 (T+90)
- 20,000 shares@ US$3.092252.1% of flowVoting Common Shares, no par value per shareSEC:0001235802-21-000099:0Canonical exit: 14 Nov 2021 (T+90)
2 of 2 declarations